Clinical and radiological evolution in patients with pulmonary Langerhans' cell histiocytosis

Netherlands Journal of Medicine

Volumn 60, Issue 8, 2002, Pages 320-326

  Westerlaan, H E ^a,b   van der Valk, P D L P M ^a  

^a MEDISCH SPECTRUM TWENTE   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ADULT; ANOREXIA; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; COUGHING; DYSPNEA; FATIGUE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTIOCYTOSIS X; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LANGERHANS CELL; LUNG BIOPSY; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; LUNG LAVAGE; MALE; OUTCOMES RESEARCH; RETROSPECTIVE STUDY; SMOKING CESSATION; SMOKING HABIT; THORAX RADIOGRAPHY; TOTAL LUNG CAPACITY; TRANSBRONCHIAL BIOPSY; TREATMENT OUTCOME; COMPUTER ASSISTED TOMOGRAPHY; LUNG; PATHOLOGY; RADIOGRAPHY; SMOKING; TIME;

ADULT; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; FOLLOW-UP STUDIES; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; LUNG; MALE; RETROSPECTIVE STUDIES; SMOKING; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0036716249     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Powers MA, Askin FB, Cresson DH. Pulmonary eosinophilic granuloma: 25-years follow-up. Am Rev Respir Dis 1984;129:503-7.
2. Farinacci CJ, Jeffrey HC, Lackey RW. Eosinophilic granuloma of the lung. U.S. Armed Forces Medical Journal 1951;2:1085.
3. Howarth DM, Gilchrist GS, Mullan BP, Wiseman GA, Edmonson JH, Schomberg PJ. Langerhans cell histiocytosis. Diagnosis, natural history, management and outcome. Cancer 1999;85:2278-90.
4. Tazi A, Soler P, Hance AJ. Adult pulmonary Langerhans cell histiocytosis. Thorax 2000;55:405-16.
5. Vassallo R, Ryu JH, Colby TV, Hartman T, Limper AH. Pulmonary Langerhans cell histiocytosis. New Engl J Med 2000;342:1969-78.
6. Cotes JE, Chinn DJ, Qwuanjer PH, Roca J, Yernault J-C. Standardization of the measurement of transfer factor (diffusing capacity). Standardised lung function testing. Official statement of the European Respiratory Society. Eur Resp J 1993;6(suppl 16):S41-S52.
7. Quanjer PH, Tammeling GJ, Cotes J, Pedersen OF, Pesin R, Yernault JC. Lung volumes and forced ventilatory flows. Standardised lung function testing. Official statement of the European Respiratory Society. Eur Resp J 1993;6(suppl 16):S5-S40.
8. Drent M, Costabel U. Bronchoalveolaire lavage in de diagnostiek van diffuse longaandoeningen. Ned T Geneeskd 1998;142:2661-5.
9. Crystal RG, Bitterman PB, Rennard SI, Hance AJ, Keogh BA. Interstitial lung diseases of unknown cause: disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med 1984;310:235-44.
10. Friedman PJ, Liebow AA, Sokoloff J. Eosinophilic granuloma of lung. Medicine 1981;60:385-96.
11. Hance AJ, Basset F, Saumon G, et al. Smoking and interstitial lung disease. The effect of cigarette smoking on the incidence of pulmonary histiocytosis X and sarcoidosis. Ann N Y Acad Sci 1986;465:643-56.
12. Casolaro MA, Bernaudin JF, Saltini C, Ferrans VJ, Crystal RG. Accumulation of Langerhans cells on the epithelial surface of the lower respiratory tracts in normal subjects in association with cigarette smoking. Am Rev Respir Dis 1988;137:406-11.
13. Tazi A, Bonay M, Grandsaigne M, Battesti JP, Hance AJ, Soler P. Surface phenotype of Langerhans cells and lymphocytes in granulomatous lesions from patients with pulmonary histiocytosis X. Am Rev Respir Dis 1993;147:1531-6.
14. Aguayo SM, King TE Jr, Waldron JA Jr, Sheritt KM, Kane MA, Miller YE. Increased pulmonary neuroendocrine cells with bombesin-like immunoreactivity in adult patients with eosinophilic granuloma. J Clin Invest 1990;86:838-44.
15. Aguayo SM. Determinants of susceptibility to cigarette smoke potential roles for neuroendocrine cells and neuropeptides in airway inflammation, airway wall remodelling, and chronic airway obstruction. Am J Respir Crit Care Med 1994;149:1692-8.
16. Tazi A, Bonay M, Bergeron A, Grandsaigne M, Hance AJ, Soler P. Role of granulocyte-macrophage colony stimulating factor (GM-CSF) in the pathogenesis of adult pulmonary histiocytosis X. Thorax 1996;51:611-4.
17. Yonkeles LH, Grizzanti JN, Liao Z, Chang CJ, Rosenstreich DL. Decreased tobacco-glycoprotein-induced lymphocyte proliferation in vitro in pulmonary eosinophilic granuloma. Am J Respir Crit Care Med 1995;151:145-50.
18. King TE Jr, Schwarz MJH, Dreisin RE, Pratt DS, Theofilopoulos AN. Circulating immune complexes in pulmonary eosinophilic granuloma. Ann Intern Med 1979;91:397-9.
19. Baliko Z, Schreiner M, Kishindy KK, Hegedüs G, Kosztolanyi GY. Different manifestations of Langerhans cell histiocytosis affecting two members of a family. Respiration 2000;67:583-5.
20. Hanapiah F, Yaacob H, Ghani KS, Hussin AS. Histiocytosis X: evidence for a genetic etiology. J Nihon Univ Sch Dent 1993;35:171-4.
21. Hirsch MS, Hong CK. Familial pulmonary histiocytosis X. Am Rev Respir Dis 1973;107:831-5.
22. Colby TV, Lombard C. Histiocytosis X in the lung. Hum Pathol 1983;14:847-56.
23. Birbeck MS, Breathnach AJ, Everall JD. An electron microcopic study of basal melanocytes and high-level clear cells (Langerhans cells) in vitiligo. J Invest Dermatol 1951;37:51-64.
24. Soler P, Chollet S, Jacque C, Fukuda Y, Ferrans VJ, Basset F. Immunocytochemical characterization of pulmonary histiocytosis X cells in lung biopsies. Am J Pathol 1985;118:439-51.
25. Auerswald U, Barth J, Magnussen H. Value of CD1 positive cells in bronchoalveolar lavage fluid for the diagnosis of pulmonary histiocytosis X. Lung 1991;169:305-9.
26. Chollet S, Soler P, Dournovo P, Richard MS, Ferrans VJ, Basset F. Diagnosis of pulmonary histiocytosis X by immunodetection of Langerhans cells in bronchoalveolar lavage fluid. Am J Pathol 1984;115:225-32.
27. Sledziewska J, Roginska E, Oblakowski P, et al. Usefulness of CD1 expression on surfaces of cells in bronchoalveolar fluid for diagnosis of histiocytosis X-our experiences. Pneumol Alergol Pol 1999;76:311-7.
28. Xaubet A, Agusti C, Picado C, et al. Bronchoalveolar lavage analysis with anti-T6 monoclonal antibody in the evaluation of diffuse lung diseases. Respiration 1989;56:161-6.
29. Wall CP, Gaensler EA, Carrington CB, Hayes JA. Comparison of transbronchial and open lung biopsies in chronic infiltrative lung diseases. Am Rev Respir Dis 1981;123:280-5.
30. Groopman JE, Golde DW. The histiocyte disorders: a pathophysiologic analysis. Ann Inter Med 1981;94:95-107.
31. Schonfeld N, Frank W, Wenig S, et al. Clinical and radiologic features, lung function and therapeutic results in pulmonary histiocytosis X. Respiration 1993;60:38-44.
32. Pomeranz SJ, Proto AV. Histiocytosis X: unusual-confusing features of eosinophilic granuloma. Chest 1986;89:88-92.
33. Brauner MW, Gremer P, Mouelhi MM, Mompoint D, Lenoir S. Pulmonary histiocytosis X: evaluation with high-resolution CT. Radiology 1989;172:255-8.
34. Bonelli FS, Hartman TE, Swenson SJ, Sherrick A. Accuracy of high-resolution CT in diagnosing lung diseases. Am J Roentgenol 1998;170:1507-21.
35. Essen S von, West W, Sitorius M, Rennard S. Complete resolution of roentgenographic changes in a patient with pulmonary histiocytosis X. Chest 1990;98:765-7.
36. Mogulkoc N, Veral A, Bishop PW, Bayindir U, Pickering CA, Egan JJ. Pulmonary Langerhans cell histiocytosis. Radiologic resolution following smoking cessation. Chest 1999;115:1452-5.
37. Delobbe A, Durieu J, Duhamel A, Wallaert B. Determinants of survival in pulmonary Langerhans cell granulomatosis (histiocytosis X). Eur Respir J 1996;9:2002-6.
38. Etienne B, Berticchi M, Gamoudes JP, Thévenet F. Relapsing pulmonary Langerhans cell histiocytosis after lung transplantation. Am J Respir Crit Care Med 1998;157:228-91.
39. Kirtland SH, Winterbauer RH. Pulmonary function tests and idiopathic pulmonary fibrosis: simple may be better. Chest 1997;111:7-8.
40. Lewis JG. Eosinophilic granuloma and its variants with special reference to lung involvement. QJ Med 1964;33:337-59.
41. Soler P, Bergeron A, Kambouchner M, et al. Is high-resolution computed tomography a reliable tool to predict the histopathological activity of pulmonary Langerhans cell histiocytosis? Am J Respir Crit Care Med 2000;162:276-0.